NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank48
Studio
Year-over-Year Change

Year-over-year net income growth rate

Percentile
P48
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q4 2025-4.05%
Q3 2025-314.68%
Q2 202556.07%
Q1 202557.12%
Q4 2024-453.72%
Q3 202457.32%
Q2 202458.40%
Q1 2024-89.45%
Q4 2023-5.01%
Q3 2023-23.09%
Q2 20238.87%
Q1 2023-10.44%
Q4 2022-0.00%
Q3 2022-233.23%
Q2 2022-5.30%
Q1 2022249.79%
Q4 2021-81.84%
Q3 2021-96.90%
Q2 2021-1.16%
Q1 2021-13508.03%
Q4 2020102.88%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%